R.W. Nelson, co-founder and chairman of the board of Kemin Industries, passed away peacefully at his home in Des Moines, Iowa ...

SEQ is now covered to monitor for recurrence in MCL patients who are in treatment-free remissionSEATTLE, April 08, 2025 ...

Thanks to the work from a Texas-based biotech and engineering company, the dire wolf is back. Learn all about the famous ...

In a stunning scientific development, the prehistoric canines made famous in the hit HBO show have been announced as the ...

XOMA's preferred shares (XOMAO, XOMAP) offer secure, attractive yields backed by biotech royalties, FDA-approved assets, and ...

Venture capital firm Andreessen Horowitz is seeking to raise about $20 billion in what will be the largest fund in its ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a notification letter from the Listing Qualifications ...

Along with the dire wolves, Colossal also announced the births of two litters of cloned red wolves, the most critically ...

Colossal Biosciences claims it has revived an extinct species, but scientists outside the company are skeptical.

To de-extinct the dire wolf, Dallas-based Colossal Biosciences extracted and sequenced ancient DNA from two fossils.

The Generative Power of AI In the biblical account of creation, God speaks, and from nothing “ex nihilo” the cosmos is formed ...

Patent eligibility under 35 U.S.C. § 101 remains one of the most hotly contested and unpredictable areas of U.S. patent law.